PMC:7029759 / 35967-36161
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T675 | 105-119 | BV_15 | denotes | immunogenicity |
| T674 | 121-128 | CHEBI:59132;CHEBI:59132 | denotes | antigen |
| T673 | 143-151 | CHEBI:60809;CHEBI:60809 | denotes | adjuvant |
| T672 | 173-181 | GO:0042571 | denotes | antibody |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T226 | 173-181 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T158 | 121-128 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
| T159 | 143-151 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T22 | 121-141 | http://purl.obolibrary.org/obo/GO_0019882 | denotes | antigen presentation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T223 | 0-194 | Sentence | denotes | Such trials should happen as soon as possible, but may prove to be challenging to get the right level of immunogenicity, antigen presentation, adjuvant addition, and potent antibody stimulation. |